Virus-specific CD4+ T-cell responses were detected in seven (70%) patients with COVID-19 and virus-specific CD8+ T-cell responses were detected in all 10 patients with COVID-19, further indicating that most individuals can develop T-cell responses to SARS-CoV-2. This evidence concerns the gene CD8A and COVID-19.